Advertisement

PentaVision

Ophthalmic Professional

Article

Bausch + Lomb Returning enVista IOLs to Market Following Voluntary Recall

After a thorough investigation in collaboration with a globally recognized TASS expert and an advisory group of nearly 30 top cataract surgeons including American Society of Cataract and Refractive Surgery leadership, the company determined that the issue stemmed from raw material used in certain lots that was delivered by a different vendor.

Ophthalmic Professional April 24, 2025
5 Key Takeaways

  • 1

    Bausch + Lomb identified the cause of the enVista IOL recall as raw material issues from a different vendor.

  • 2

    The company collaborated with a TASS expert and top cataract surgeons to investigate the recall.

  • 3

    Bausch + Lomb is returning enVista IOLs to market after confirming safety and implementing enhanced inspection protocols.

  • 4

    The company will resume full production of enVista IOLs and plans to restore market supply in the U.S. soon.

  • 5

    Bausch + Lomb will discuss the financial impacts of the recall during its April 30 first-quarter earnings call.